About Us
Main Menu
Blog
Contact
Log In

HomeBlogVideoFinerenone & Heart Risk

Finerenone & Heart Risk

October 23, 2025

1 min read

CKD finerenon heart risk

Search

Recent Posts

Atrasentan in IgA Nephropathy: Who Might Benefit, What ALIGN Shows, and Is the Cost Justified?
IgA Nephropathy in 2026: New Medications, Patient Selection, and a Practical Treatment Review
CKM Syndrome: The Missing Link
Landmark Studies in Nephrology, 2006–2026: The 10 Trials That Changed Practice
GLP-1 Therapies and the Kidney: From Glucose Lowering to Cardiorenal–Metabolic Medicine

Recent Comments

No comments to show.

Recent Posts

Atrasentan in IgA Nephropathy: Who Might Benefit, What ALIGN Shows, and Is the Cost Justified?September 9, 2026
IgA Nephropathy in 2026: New Medications, Patient Selection, and a Practical Treatment ReviewAugust 23, 2026
CKM Syndrome: The Missing LinkAugust 20, 2026
Landmark Studies in Nephrology, 2006–2026: The 10 Trials That Changed PracticeAugust 19, 2026
GLP-1 Therapies and the Kidney: From Glucose Lowering to Cardiorenal–Metabolic MedicineAugust 18, 2026

Tag Cloud

Cardio-Renal-Metabolic CKD CKM CRM finerenon Global heart risk indigenous Nature

Comprehensive educational platform for nephrology professionals featuring interactive chapters, presentations, assessments, and the latest research updates.

About
Contact

Services

Document Library
Self Assignments
Chapters
Interactive Cases
Guidelines
Articles

Follow Us

Facebook
Twitter
LinkedIn

© 2026 · Kidney-hub

About Us
Main Menu
Blog
Contact
Log In

Ask Kidney Hub AI

AI Assistant

Online

Transcribing audio...

Listening...